Stocks
LifeStance Health Group Financial Statements (LFST) |
||||||||||
| LifeStance Health Groupsmart-lab.ru | % | 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 31.12.2020 | 17.03.2022 | 31.12.2022 | 09.03.2023 | 31.12.2023 | 09.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 377.2 | 667.5 | 859.5 | 859.5 | 1 056 | 1 104 | |||
| Operating Income, bln rub | 15.4 | -286.4 | -210.2 | -210.2 | -187.3 | -170.7 | ||||
| EBITDA, bln rub | ? | 46.5 | -233.7 | -109.3 | -141.2 | -106.9 | -86.8 | |||
| Net profit, bln rub | ? | -38.1 | -307.2 | -215.6 | -215.6 | -186.3 | -173.1 | |||
| OCF, bln rub | ? | -8.53 | 9.42 | 52.8 | 52.8 | -16.9 | -30.8 | |||
| CAPEX, bln rub | ? | 38.1 | 94.5 | 79.3 | 79.3 | 40.5 | 37.9 | |||
| FCF, bln rub | ? | -46.6 | -85.1 | -26.5 | -26.5 | -57.4 | -68.7 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 330.7 | 487.9 | 1 070 | 447.2 | 409.0 | 453.2 | ||||
| Cost of production, bln rub | 242.9 | 466.0 | 0.000 | 622.5 | 834.0 | 821.1 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 22.1 | 38.9 | 19.9 | 19.9 | 21.2 | 22.0 | ||||
| Assets, bln rub | 1 570 | 1 927 | 2 174 | 2 174 | 2 233 | 2 106 | ||||
| Net Assets, bln rub | ? | 997.8 | 1 545 | 1 519 | 1 519 | 1 429 | 1 429 | |||
| Debt, bln rub | 362.5 | 157.4 | 476.5 | 476.5 | 511.0 | 505.8 | ||||
| Cash, bln rub | 18.8 | 148.0 | 108.6 | 108.6 | 78.8 | 49.5 | ||||
| Net debt, bln rub | 343.7 | 9.39 | 367.9 | 367.9 | 432.2 | 456.3 | ||||
| Ordinary share price, rub | 9.52 | 4.94 | 4.94 | 7.83 | 5.95 | |||||
| Number of ordinary shares, mln | 373.6 | 327.5 | 355.3 | 355.3 | 367.5 | 376.3 | ||||
| Market cap, bln rub | 0 | 3 118 | 1 755 | 1 755 | 2 877 | 2 239 | ||||
| EV, bln rub | ? | 344 | 3 127 | 2 123 | 2 123 | 3 309 | 2 695 | |||
| Book value, bln rub | -434 | 40 | -18 | -18 | -85 | -73 | ||||
| EPS, rub | ? | -0.10 | -0.94 | -0.61 | -0.61 | -0.51 | -0.46 | |||
| FCF/share, rub | -0.12 | -0.26 | -0.07 | -0.07 | -0.16 | -0.18 | ||||
| BV/share, rub | -1.16 | 0.12 | -0.05 | -0.05 | -0.23 | -0.19 | ||||
| EBITDA margin, % | ? | 12.3% | -35.0% | -12.7% | -16.4% | -10.1% | -7.87% | |||
| Net margin, % | ? | -10.1% | -46.0% | -25.1% | -25.1% | -17.6% | -15.7% | |||
| FCF yield, % | ? | -2.73% | -1.51% | -1.51% | -2.00% | -3.07% | ||||
| ROE, % | ? | -3.82% | -19.9% | -14.2% | -14.2% | -13.0% | -12.1% | |||
| ROA, % | ? | -2.43% | -15.9% | -9.92% | -9.92% | -8.34% | -8.22% | |||
| P/E | ? | 0.00 | -10.1 | -8.14 | -8.14 | -15.4 | -12.9 | |||
| P/FCF | 0.00 | -36.7 | -66.3 | -66.3 | -50.1 | -32.6 | ||||
| P/S | ? | 0.00 | 4.67 | 2.04 | 2.04 | 2.73 | 2.03 | |||
| P/BV | ? | 0.00 | 77.7 | -100.2 | -100.2 | -33.7 | -30.7 | |||
| EV/EBITDA | ? | 7.39 | -13.4 | -19.4 | -15.0 | -31.0 | -31.0 | |||
| Debt/EBITDA | 7.39 | -0.04 | -3.37 | -2.61 | -4.04 | -5.26 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| CAPEX/Revenue, % | 10.1% | 14.2% | 9.22% | 9.22% | 3.84% | 3.43% | ||||
| LifeStance Health Group shareholders | ||||||||||
